-
Document de presse | 2024.03.28
Inauguration in Brazil of the Institut Pasteur de São Paulo, member of the Pasteur Network
On March 27, 2024, the Institut Pasteur de São Paulo was inaugurated by French President, Emmanuel Macron. As a member of the Pasteur Network, this institute, founded by the Institut Pasteur and the University of São Paulo, conducts international-level research in the field of health biology to further understanding of diseases and their impact on human health, especially in the context of...
-
News | 2024.03.27
Cancer: unexpected mechanism of action of immunotherapy revealed
Immunotherapy, now in widespread use as a treatment for cancer, continues to be a focus of research and to teach us more about the immune system. A new study by scientists at the Institut Pasteur has identified a novel mechanism of action of anti-PD-1 antibodies, a commonly used form of immunotherapy.
-
News | 2024.05.15
The untapped potential of cycling for public health and the climate
A national study has revealed that cycling benefits health, the economy and the climate in France. The findings show that cycling can prevent nearly 2,000 deaths each year and that every kilometer cycled saves €1 in medical costs. The unprecedented study was conducted by researchers in the joint CNAM-Institut Pasteur PACRI unit, in collaboration with the CNRS.
-
News | 2024.04.04
AMAZED: harnessing the potential of the Pasteur Network to investigate vector-borne diseases
The Institut Pasteur is involved in AMAZED, a multidisciplinary project to study the mechanisms behind the emergence of arboviruses, in other words pathogens transmitted by insect vectors. The project, coordinated by the Institut Pasteur de la Guyane, brings together the Institut Pasteur and three members of the Pasteur Network in France's overseas territories (French Guiana, Guadeloupe and New...
-
News | 2024.04.02
The gut microbiota: an incredibly rich ecosystem
We call it the "second brain," but what exactly is it? What do we know about it today, and what are the medical applications? Five scientists addressed these questions in the public conference "The gut microbiota: towards new health practices," held at the Institut Pasteur in connection with Brain Awareness Week.
-
News | 2024.04.08
Interested in helping to shape the Institut Pasteur of tomorrow? We're open to ideas!
We invite you to join our discussion group on the image and perception of the Institut Pasteur to hear your opinion and suggestions.
-
News | 2023.06.06
HIV-AIDS: natural killer cells that target HIV
African green monkeys are able to live while being infected with the simian immunodeficiency virus (SIV) without ever developing AIDS. Their hint? Directly eliminate infected cells, without causing an inflammatory reaction that the virus could use to its advantage.
-
News | 2023.09.05
HIV-AIDS: broadly neutralizing antibodies, stars of the lab
Highly promising, broadly neutralizing antibodies can react with the vast majority of HIV particles to cause their destruction by the body. However, the latter would have to be able to produce equally effective antibodies...
-
News | 2023.07.10
HIV-AIDS: a virus master of evasion
Developing effective therapeutic vaccines requires knowing how to chemically recognize microbes, as well as exposing them to treatment. Able to mutate very quickly and to camouflage itself inside the cells it infects, the AIDS virus (or HIV) constitutes a challenge for researchers.
-
News | 2023.01.12
Improving our understanding of insect vectors to curb disease outbreaks
A few weeks after the book Le moustique, ennemi public n°1? , published by Quae, Anna-Bella Failloux, researcher at the Institut Pasteur and co-author of the book, looks back on the Pasteurian expertise on vector-borne diseases.
